Literature DB >> 1647995

Association of Metformin's effect to increase insulin-stimulated glucose transport with potentiation of insulin-induced translocation of glucose transporters from intracellular pool to plasma membrane in rat adipocytes.

S Matthaei1, A Hamann, H H Klein, H Benecke, G Kreymann, J S Flier, H Greten.   

Abstract

To examine the cellular mechanism of the antihyperglycemic action of metformin, we studied its effect on various functional and molecular parameters involved in the pathogenesis of insulin resistance. Isolated rat adipocytes were incubated with or without metformin (1-100 micrograms/ml) for 2 h at 37 degrees C followed by an incubation with or without insulin (1.72 nM). Metformin treatment had no significant effect on basal 3-O-methylglucose uptake. In contrast, metformin increased insulin-stimulated glucose transport in a dose-dependent manner up to 43 +/- 7%. This effect was neither associated with a significant effect of metformin on trace insulin binding (1.74 +/- 0.20% without metformin vs. 1.89 +/- 0.30% with metformin; P greater than 0.05) nor with an effect of metformin on insulin-receptor kinase activity as measured by 32P incorporation into the 95,000-Mr beta-subunit of the insulin receptor and an exogenous substrate, histone 2B.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647995     DOI: 10.2337/diab.40.7.850

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  20 in total

1.  Chronic insulin effects on insulin signalling and GLUT4 endocytosis are reversed by metformin.

Authors:  P R Pryor; S C Liu; A E Clark; J Yang; G D Holman; D Tosh
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

2.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain.

Authors:  M R Owen; E Doran; A P Halestrap
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

3.  Troglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocytes.

Authors:  K L Anil Kumar; A R Marita
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 4.  A risk-benefit assessment of metformin in type 2 diabetes mellitus.

Authors:  H C Howlett; C J Bailey
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

Review 5.  The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms.

Authors:  N F Wiernsperger; C J Bailey
Journal:  Drugs       Date:  1999       Impact factor: 9.546

6.  Metformin enhances insulin signalling in insulin-dependent and-independent pathways in insulin resistant muscle cells.

Authors:  Naresh Kumar; Chinmoy S Dey
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

Review 7.  Molecular mechanism of insulin resistance in obesity and type 2 diabetes.

Authors:  Kangduk Choi; Young-Bum Kim
Journal:  Korean J Intern Med       Date:  2010-06-01       Impact factor: 3.165

8.  Metformin ameliorates diabetes but does not normalize the decreased GLUT 4 content in skeletal muscle of obese (fa/fa) Zucker rats.

Authors:  A Handberg; L Kayser; P E Høyer; M Voldstedlund; H P Hansen; J Vinten
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

9.  Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin.

Authors:  V Sarabia; L Lam; E Burdett; L A Leiter; A Klip
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 10.  Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  B H Wolffenbuttel; T W van Haeften
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.